Feasibility and Acceptability of a Body Dissatisfaction Program in Eating Disorders Patients

September 6, 2021 updated by: University Hospital, Montpellier

Preliminary Study Evaluating Feasibility and Acceptability of a Psychological Management Program Focused on Body Dissatisfaction in Eating Disorders. SABG : Secondary Alveolar Bone Grafting

The cognitive model of Eating Disorders (ED) highlights dysfunctional cognitive patterns common to the different subtypes. Body dissatisfaction, which can be defined as the negative and subjective evaluation of one's body shape, i.e., negative thoughts and emotions concerning one's body image and the origin of pathological behaviours with the aim of modifying one's weight and body shape, thus appears to be a central transdiagnostic concept in the ED. It is, moreover, described as a major factor in the development, maintenance and relapse of the various types of ED.

It is suggested that Acceptance and Commitment Therapy (ACT) may be beneficial in treating body dissatisfaction insofar as body image inflexibility appears to influence the relationship between body image appraisal and coping strategies. ACT, which aims to develop psychological flexibility, appeared to us as a promising tool to manage body dissatisfaction in ED.

The investigators therefore aim to evaluate the feasibility and acceptability of a psychological management group for body dissatisfaction (9 or 10 weekly group session), based on ACT therapy, in patients suffering from an ED.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

18

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34295
        • UHMontpellier

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Eating Disorders patients participating in a body dissatisfaction management program

Description

Inclusion criteria:

  • Women over 16 years
  • Eating disorder, according to DSM-5 criteria (all types of eating disorder are included: anorexia, bulimia, binge eating disorder, …)
  • Marked body dissatisfaction
  • BMI > 17.5 kg/m2

Exclusion criteria:

  • Refusal to participate
  • Current severe psychiatric condition other than an ED that may impair patients' ability to attend the group
  • Pregnant or breastfeeding women
  • Protection measure or deprivation of liberty by administrative decision

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of the body dissatisfaction program
Time Frame: Day 1
Participation rate in group sessions
Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptability of the body dissatisfaction program
Time Frame: day 1
Satisfaction survey
day 1
Evolution of the eating disorder symptomatology
Time Frame: day 1
Eating disorder symptomatology assessed with the Eating Disorder Examination (EDE-Q). Higher scores on the global scale and
day 1
Evolution of the eating disorder symptomatology
Time Frame: day 1
Eating disorder symptomatology assessed with the Eating Disorder Inventory (EDI-2). Higher scores on the global scale and subscales indicate more severe disorder.
day 1
Evolution of the body dissatisfaction level
Time Frame: day 1
Level of body dissatisfaction assessed with EDE-Q body weight and shape concerns subscales. Higher scores indicate higher body dissatisfaction
day 1
Quality of life evolution
Time Frame: day 1
Quality of life assessed with Eating Disorders Quality Of Life
day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Sébastien Guillaume, MD.PhD, University Hospital, Montpellier

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 1, 2019

Primary Completion (ACTUAL)

February 1, 2020

Study Completion (ACTUAL)

February 20, 2020

Study Registration Dates

First Submitted

September 1, 2021

First Submitted That Met QC Criteria

September 6, 2021

First Posted (ACTUAL)

September 13, 2021

Study Record Updates

Last Update Posted (ACTUAL)

September 13, 2021

Last Update Submitted That Met QC Criteria

September 6, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RECHMPL21_0551

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

NC

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Eating Disorders

3
Subscribe